Test Price
190 AED✅ Home Collection Available
Glomerular Basement Membrane (GBM) Antibody IFA Test in UAE | 190 AED | DHA Licensed
Executive Summary & Core Metrics
Clinical Certainty, UAE-Compliant Delivery
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited indirect immunofluorescence on primate kidney substrate, ensuring optimal detection of conformational anti-GBM epitopes.
- Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM across all UAE emirates.
- Clinical Guidance: Post-test telephonic interpretation support from a DHA-licensed general practitioner.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
- Turnaround: Same-day report when sample is collected by 11 AM.
Test Overview & Methodology
The Glomerular Basement Membrane (GBM) Antibody IFA test detects circulating autoantibodies against type IV collagen alpha-3 chain, the hallmark of anti-GBM disease (Goodpasture syndrome). In the UAE, this same-day serum analysis provides rapid, definitive immunological evidence for rapidly progressive glomerulonephritis, enabling timely therapeutic plasma exchange or immunosuppression. The methodology employs indirect immunofluorescence on native primate kidney tissue, preserving conformational epitopes for maximal diagnostic sensitivity.
| Feature | Our GBM IFA (DHA-Accredited) | Standard ELISA Alternative |
|---|---|---|
| Precision / Epitope Integrity | Indirect IFA on native primate kidney – preserves conformational type IV collagen epitopes; detects both IgG and IgA subtypes | Recombinant alpha-3(IV)NC1 antigen – may miss rare non-alpha-3 reactivity; limited subclass detection |
| Diagnostic Speed | Same-day report (sample by 11 AM) | Often 24–72 h batch processing |
| Clinical Correlation | Direct visual semi-quantitation of antibody binding pattern; gold standard for anti-GBM disease per KDIGO guidelines | Quantitative units/mL; may require confirmatory IFA or biopsy |
| UAE Regulatory Compliance | Full DHA/MOHAP nomenclature, PDPL-aligned, ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Varies by external lab; may lack local accreditation |
Physician Insight & Safety Protocols
“A positive anti-GBM antibody result is a critical clinical signal that warrants immediate nephrology referral. Early serological detection can preserve renal function and guide life-saving intervention. Patients presenting with unexplained hematuria, subnephrotic proteinuria, or rapid decline in estimated glomerular filtration rate should be tested promptly. Always correlate serology with renal biopsy and pulmonary imaging for a complete diagnostic picture.”
— Dr. Ajay Singh, General Practitioner | DHA Registration ID: 36234132
Medication Advisory
⚠ Medication Warning
Do not discontinue any prescribed immunosuppressive, antihypertensive, or corticosteroid medication without consulting your treating physician. Abrupt cessation may trigger disease flare or life-threatening adrenal crisis. This test is a diagnostic aid, not a substitute for ongoing clinical management.
Safety Exclusion Criteria & Emergency Red Flags
🟠 Exclusion & Emergency Protocol
- Exclusion Criteria: Active hemodynamic instability (systolic BP below 90 mmHg), inability to provide informed consent, or known severe coagulopathy (INR above 2.0) without medical clearance – home collection is not advised in these scenarios.
- Emergency Red Flags (seek emergency care immediately): Sudden massive hemoptysis (coughing up blood), oliguria/anuria (less than 100 mL urine per 24 hours), severe dyspnea at rest, or altered mental status. These may indicate fulminant pulmonary-renal syndrome.
- Minor Consent Requirement: All individuals under 18 require a legal guardian present during sample collection; valid Emirates ID and guardian consent are mandatory per Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. How should I prepare for the GBM antibody IFA blood test?
Preparation: Overnight fasting of 8 to 12 hours is preferred. Inform the phlebotomist of all current medications, especially immunosuppressants and anticoagulants. No special diet is required; however, avoid heavy fatty meals before the draw as lipemic serum may interfere with fluorescence interpretation.
2. What does a positive anti-GBM result mean for my kidneys?
Clinical Significance: A positive result indicates a high likelihood of rapidly progressive glomerulonephritis requiring immediate immunosuppressive therapy and plasma exchange. False-positive results are rare but can occur in polyclonal gammopathies; confirmation with renal biopsy and pulmonary imaging is always recommended.
3. Can I get this test done at home in Dubai or Abu Dhabi on the same day?
Home Collection Availability: Yes, our ISO-certified VIP mobile phlebotomy teams cover all UAE emirates from 8 AM to 11 PM with same-day reporting. Simply WhatsApp +971 54 548 8731 to verify your insurance coverage and schedule a visit at your convenience.
4. How is the GBM antibody IFA test different from a standard ELISA test?
Methodology Difference: The IFA method uses native primate kidney tissue preserving the full conformational structure of type IV collagen, allowing detection of both IgG and IgA antibody subtypes. ELISA uses recombinant antigens which may miss rare non-alpha-3 reactivities. IFA remains the gold standard per international guidelines for anti-GBM disease diagnosis.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
- Data Protection: All patient data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL). Your health information is encrypted, access-controlled, and never shared without explicit consent.
- Health ICT Governance: Laboratory information systems and telemedicine protocols adhere to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring secure digital health data exchange.
- Medical Liability & Consent: All clinical procedures, including sample collection and result disclosure, follow the standards set by Federal Decree-Law No. 4 of 2016 on Medical Liability, guaranteeing patient safety and informed consent.
- Accreditation: ISO 9001:2015 Certified Medical Laboratory (Cert: INT/EGQ/2509DA/3139). Licensed by DHA and MOHAP.
Clinical & Logistical Metadata
| Test Name | Glomerular Basement Membrane (GBM) Antibody IFA Test |
| Price (AED) | 190 |
| Turnaround Time | Same-day (sample collected by 11 AM) |
| Sample Type / Matrix | Serum (peripheral whole blood) |
| Methodology Used | Indirect Immunofluorescence Assay (IFA) on primate kidney substrate |
| ICD-10-CM Code | M31.0, N01.7, Z13.220 |
| LOINC Code | 16183-0 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians